Dr. Santoshi R. Ghodake* and Dr. Adinath N. Suryakar


Objective: Neuropsychiatric disorders represent the second largest cause of morbidity worldwide having very complex etiopathophysiology. Several lines of evidence suggesting that inflammatory reactions are most common features of all forms of neuronal disorders. There is growing evidences also suggests increased oxidative stress and inflammation in patients with schizophrenia. To assess the lipid peroxidation, Malondialdehyde (MDA), Total antioxidant capacity (TAC) uric acid were estimated. To estimate the activity of Adenosine deaminase (ADA) as inflammatory marker in neuropsychiatric disorders. Also study was aimed to assess the impact of antioxidant supplementation on these parameters in patients with neuropsychiatric disorders. Method: The study group included a total of 90 subjects of which 30 were schizophrenic patients, 30 were major depressive patients and 30 were healthy controls. Statistical analysis was performed using student 't'test. Results: Serum MDA (Group I, p<0.0001 Group II, p<0.05) and ADA (Group I, p< 0.0001, Group II, p<0.05) levels were found to be significantly high in both group patients (schizophrenics and depression) when compared to controls. Significant decreased levels of TAC (Group I and II, p<0.0001) and uric acid (Group I and II, p<0.05) level in were observed in both groups. After antioxidants supplementation significant changes were found in the levels of MDA, TAC, uric acid and ADA activity. Conclusion: We conclude that increased serum ADA activity indicates inflammation and increased MDA level indicates oxidative stress in neuropsychiatric disorders, schizophrenia and depression. The data showed that decrease in plasma TAC and uric acid, suggesting increased oxidative stress. Inflammatory biomarkers are known to play an important role in initiation and progression of disease along with oxidative damage.

Keywords: Adenosine deaminase, Malondialdehyde, Oxidative stress, Inflammation, Neuropsychiatric disorders.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MAY 2024 Issue has been successfully launched on 1 MAY 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction